Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

MicroRNAs in Obesity and Related Metabolic Disorders.

Landrier JF, Derghal A, Mounien L.

Cells. 2019 Aug 9;8(8). pii: E859. doi: 10.3390/cells8080859. Review.

2.

Anti-Obesity Effect of Carotenoids: Direct Impact on Adipose Tissue and Adipose Tissue-Driven Indirect Effects.

Mounien L, Tourniaire F, Landrier JF.

Nutrients. 2019 Jul 11;11(7). pii: E1562. doi: 10.3390/nu11071562. Review.

3.

Obesity and Vitamin D Metabolism Modifications.

Landrier JF, Mounien L, Tourniaire F.

J Bone Miner Res. 2019 Jul;34(7):1383. doi: 10.1002/jbmr.3739. Epub 2019 May 29. No abstract available.

PMID:
31141222
4.

(all-E)- and (5Z)-Lycopene Display Similar Biological Effects on Adipocytes.

Fenni S, Astier J, Bonnet L, Karkeni E, Gouranton E, Mounien L, Couturier C, Tourniaire F, Böhm V, Hammou H, Landrier JF.

Mol Nutr Food Res. 2019 Mar;63(5):e1800788. doi: 10.1002/mnfr.201800788. Epub 2018 Dec 27.

PMID:
30512227
5.

MicroRNAs are involved in the hypothalamic leptin sensitivity.

Derghal A, Djelloul M, Azzarelli M, Degonon S, Tourniaire F, Landrier JF, Mounien L.

Epigenetics. 2018;13(10-11):1127-1140. doi: 10.1080/15592294.2018.1543507. Epub 2018 Nov 11.

PMID:
30395773
6.

The Role of MicroRNA in the Modulation of the Melanocortinergic System.

Derghal A, Djelloul M, Trouslard J, Mounien L.

Front Neurosci. 2017 Apr 5;11:181. doi: 10.3389/fnins.2017.00181. eCollection 2017. Review.

7.

An Emerging Role of micro-RNA in the Effect of the Endocrine Disruptors.

Derghal A, Djelloul M, Trouslard J, Mounien L.

Front Neurosci. 2016 Jun 30;10:318. doi: 10.3389/fnins.2016.00318. eCollection 2016. Review.

8.

Leptin is required for hypothalamic regulation of miRNAs targeting POMC 3'UTR.

Derghal A, Djelloul M, Airault C, Pierre C, Dallaporta M, Troadec JD, Tillement V, Tardivel C, Bariohay B, Trouslard J, Mounien L.

Front Cell Neurosci. 2015 May 6;9:172. doi: 10.3389/fncel.2015.00172. eCollection 2015.

9.

Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis.

Tarussio D, Metref S, Seyer P, Mounien L, Vallois D, Magnan C, Foretz M, Thorens B.

J Clin Invest. 2014 Jan;124(1):413-24. doi: 10.1172/JCI69154. Epub 2013 Dec 16.

10.

Gastric distension activates NUCB2/nesfatin-1-expressing neurons in the nucleus of the solitary tract.

Bonnet MS, Ouelaa W, Tillement V, Trouslard J, Jean A, Gonzalez BJ, Gourcerol G, Dallaporta M, Troadec JD, Mounien L.

Regul Pept. 2013 Nov 10;187:17-23. doi: 10.1016/j.regpep.2013.10.001. Epub 2013 Oct 10.

PMID:
24120633
11.

Advances in deoxynivalenol toxicity mechanisms: the brain as a target.

Bonnet MS, Roux J, Mounien L, Dallaporta M, Troadec JD.

Toxins (Basel). 2012 Nov 1;4(11):1120-38. doi: 10.3390/toxins4111120. Review. Corrected and republished in: J Food Sci. 2015 Dec;80(12):T2970-83.

12.

Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations.

Mannstadt M, Magen D, Segawa H, Stanley T, Sharma A, Sasaki S, Bergwitz C, Mounien L, Boepple P, Thorens B, Zelikovic I, Jüppner H.

J Clin Endocrinol Metab. 2012 Oct;97(10):E1978-86. doi: 10.1210/jc.2012-1279. Epub 2012 Aug 3.

13.

The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing.

Delaere F, Duchampt A, Mounien L, Seyer P, Duraffourd C, Zitoun C, Thorens B, Mithieux G.

Mol Metab. 2012 Dec 7;2(1):47-53. doi: 10.1016/j.molmet.2012.11.003. eCollection 2012.

14.

The food-contaminant deoxynivalenol modifies eating by targeting anorexigenic neurocircuitry.

Girardet C, Bonnet MS, Jdir R, Sadoud M, Thirion S, Tardivel C, Roux J, Lebrun B, Wanaverbecq N, Mounien L, Trouslard J, Jean A, Dallaporta M, Troadec JD.

PLoS One. 2011;6(10):e26134. doi: 10.1371/journal.pone.0026134. Epub 2011 Oct 12.

15.

Central inflammation and sickness-like behavior induced by the food contaminant deoxynivalenol: a PGE2-independent mechanism.

Girardet C, Bonnet MS, Jdir R, Sadoud M, Thirion S, Tardivel C, Roux J, Lebrun B, Mounien L, Trouslard J, Jean A, Dallaporta M, Troadec JD.

Toxicol Sci. 2011 Nov;124(1):179-91. doi: 10.1093/toxsci/kfr219. Epub 2011 Aug 26.

PMID:
21873375
16.

Glut2-dependent glucose-sensing controls thermoregulation by enhancing the leptin sensitivity of NPY and POMC neurons.

Mounien L, Marty N, Tarussio D, Metref S, Genoux D, Preitner F, Foretz M, Thorens B.

FASEB J. 2010 Jun;24(6):1747-58. doi: 10.1096/fj.09-144923. Epub 2010 Jan 22.

PMID:
20097878
17.

The orexigenic activity of the hypothalamic neuropeptide 26RFa is mediated by the neuropeptide Y and proopiomelanocortin neurons of the arcuate nucleus.

Lectez B, Jeandel L, El-Yamani FZ, Arthaud S, Alexandre D, Mardargent A, Jégou S, Mounien L, Bizet P, Magoul R, Anouar Y, Chartrel N.

Endocrinology. 2009 May;150(5):2342-50. doi: 10.1210/en.2008-1432. Epub 2009 Jan 22.

PMID:
19164468
18.

Pituitary adenylate cyclase-activating polypeptide inhibits food intake in mice through activation of the hypothalamic melanocortin system.

Mounien L, Do Rego JC, Bizet P, Boutelet I, Gourcerol G, Fournier A, Brabet P, Costentin J, Vaudry H, Jégou S.

Neuropsychopharmacology. 2009 Jan;34(2):424-35. doi: 10.1038/npp.2008.73. Epub 2008 Jun 4.

19.

Tumor necrosis factor (TNF)-alpha persistently activates nuclear factor-kappaB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation.

Ait-Ali D, Turquier V, Tanguy Y, Thouënnon E, Ghzili H, Mounien L, Derambure C, Jégou S, Salier JP, Vaudry H, Eiden LE, Anouar Y.

Endocrinology. 2008 Jun;149(6):2840-52. doi: 10.1210/en.2007-1192. Epub 2008 Feb 21.

20.

Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat.

Bruzzone F, Lectez B, Alexandre D, Jégou S, Mounien L, Tollemer H, Chatenet D, Leprince J, Vallarino M, Vaudry H, Chartrel N.

J Comp Neurol. 2007 Aug 1;503(4):573-91.

PMID:
17534937

Supplemental Content

Loading ...
Support Center